{
  "id": "61ddf7dc87dc9671",
  "title": "Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late - Stage Metastatic Triple - Negative Breast Cancer",
  "description": "20260127T161500Z",
  "content": "",
  "source": "vietnamtribune.com",
  "source_url": "http://www.vietnamtribune.com/news/278833687/kazia-therapeutics-reports-encouraging-preliminary-clinical-responses-in-ongoing-phase-1b-study-of-paxalisib-in-late-stage-metastatic-triple-negative-breast-cancer",
  "published_at": "20260127T161500Z",
  "fetched_at": "2026-01-28T00:24:25.269376+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "aging"
  ],
  "location": "Vietnam",
  "raw_data": {
    "url": "http://www.vietnamtribune.com/news/278833687/kazia-therapeutics-reports-encouraging-preliminary-clinical-responses-in-ongoing-phase-1b-study-of-paxalisib-in-late-stage-metastatic-triple-negative-breast-cancer",
    "url_mobile": "",
    "title": "Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late - Stage Metastatic Triple - Negative Breast Cancer",
    "seendate": "20260127T161500Z",
    "socialimage": "",
    "domain": "vietnamtribune.com",
    "language": "English",
    "sourcecountry": "Vietnam"
  }
}